These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 18991752)

  • 1. Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview.
    Correia S; Carvalho C; Santos MS; Seiça R; Oliveira CR; Moreira PI
    Mini Rev Med Chem; 2008 Nov; 8(13):1343-54. PubMed ID: 18991752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin: an update.
    Kirpichnikov D; McFarlane SI; Sowers JR
    Ann Intern Med; 2002 Jul; 137(1):25-33. PubMed ID: 12093242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved endothelial function with metformin in type 2 diabetes mellitus.
    Mather KJ; Verma S; Anderson TJ
    J Am Coll Cardiol; 2001 Apr; 37(5):1344-50. PubMed ID: 11300445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fixed-dose combination of pioglitazone and metformin: A promising alternative in metabolic control.
    Seufert J
    Curr Med Res Opin; 2006; 22 Suppl 2():S39-48. PubMed ID: 16914074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summaries for patients. Metformin for patients with type 2 diabetes mellitus.
    Ann Intern Med; 2002 Jul; 137(1):I50. PubMed ID: 12093266
    [No Abstract]   [Full Text] [Related]  

  • 8. Metformin and risk of cardiovascular disease.
    Turner RC; Holman RR
    Cardiology; 1999; 91(3):203-4. PubMed ID: 10516415
    [No Abstract]   [Full Text] [Related]  

  • 9. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
    An H; He L
    J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
    Bosi E
    Diabetes Obes Metab; 2009 May; 11 Suppl 2():3-8. PubMed ID: 19385978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin: an antihyperglycemic agent for treatment of type II diabetes.
    Melchior WR; Jaber LA
    Ann Pharmacother; 1996 Feb; 30(2):158-64. PubMed ID: 8835050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin hydrochloride: an antihyperglycemic agent.
    Klepser TB; Kelly MW
    Am J Health Syst Pharm; 1997 Apr; 54(8):893-903. PubMed ID: 9114921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect.
    Saisho Y
    Endocr Metab Immune Disord Drug Targets; 2015; 15(3):196-205. PubMed ID: 25772174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin in noninsulin-dependent diabetes mellitus.
    Lee AJ
    Pharmacotherapy; 1996; 16(3):327-51. PubMed ID: 8726592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications].
    Wolffenbuttel BH; Heine RJ
    Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1197-201. PubMed ID: 10389533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up.
    Fisman EZ; Tenenbaum A; Benderly M; Goldbourt U; Behar S; Motro M
    Cardiology; 1999; 91(3):195-202. PubMed ID: 10516414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin; an old antidiabetic drug with new potentials in bone disorders.
    Bahrambeigi S; Yousefi B; Rahimi M; Shafiei-Irannejad V
    Biomed Pharmacother; 2019 Jan; 109():1593-1601. PubMed ID: 30551413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients.
    Mary A; Hartemann A; Liabeuf S; Aubert CE; Kemel S; Salem JE; Cluzel P; Lenglet A; Massy ZA; Lalau JD; Mentaverri R; Bourron O; Kamel S
    Cardiovasc Diabetol; 2017 Feb; 16(1):24. PubMed ID: 28202017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemic agents in the management of type 2 diabetes mellitus.
    Ho J; Leung AK; Rabi D
    Recent Pat Endocr Metab Immune Drug Discov; 2011 Jan; 5(1):66-73. PubMed ID: 22074580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
    Guppy A; Jamal-Hanjani M; Pickering L
    Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.